0001140361-17-001375.txt : 20170110
0001140361-17-001375.hdr.sgml : 20170110
20170110165032
ACCESSION NUMBER: 0001140361-17-001375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170109
FILED AS OF DATE: 20170110
DATE AS OF CHANGE: 20170110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 17521058
MAIL ADDRESS:
STREET 1: 3172 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94034
4
1
doc1.xml
FORM 4
X0306
4
2017-01-09
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001238403
SPIEGELMAN DANIEL K
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2017-01-09
2017-01-09
4
S
0
5000
90.00
D
18100
D
Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.
All shares were sold at the same price.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2017-01-10